[Post therapeutic cervical cancer surveillance in France: Priority for examination]

Gynecol Obstet Fertil Senol. 2018 May;46(5):503-505. doi: 10.1016/j.gofs.2018.03.004. Epub 2018 Mar 31.

[Article in French]

Authors

C Bourgin¹, J P Estevez², P Collinet²

Affiliations

¹ Service de gynécologie, CHRU Jeanne-de-Flandre, 2, avenue Eugène-Aviné, 59000 Lille, France. Electronic address: charlotte.bourgin@chru-lille.fr.
² Service de gynécologie, CHRU Jeanne-de-Flandre, 2, avenue Eugène-Aviné, 59000 Lille, France.

PMID: 29615374
DOI: 10.1016/j.gofs.2018.03.004

No abstract available

Keywords: Cancer du col; Cervical cancer; Surveillance.

MeSH terms

Biomarkers, Tumor / blood
Female
France
Humans
Magnetic Resonance Imaging
Neoplasm Recurrence, Local / diagnosis*
Papillomaviridae / isolation & purification
Tomography, X-Ray Computed
Uterine Cervical Neoplasms / diagnosis
Uterine Cervical Neoplasms / pathology*
Uterine Cervical Neoplasms / therapy

Substances

Biomarkers, Tumor